本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mersana Therapeutics Inc.

0.3029
-0.0032-1.05%
盘后0.2951-0.0078-2.58%19:54 EDT
成交量:234.83万
成交额:73.10万
市值:3,775.08万
市盈率:-0.54
高:0.3312
开:0.3084
低:0.2910
收:0.3061
数据加载中...
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/28

重要事件披露

Form 8-K - Current report
2025/02/05

重要事件披露

Form 8-K - Current report
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/10

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]